SOPH
SOPHiA GENETICS SA
8.30$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 30.9% | 30.2% | 34.1% | 31.8% | 32.8% | 31.8% | 31.3% | 33.0% | 33.7% | 32.3% | 32.0% | 35.4% | 33.4% | |
| 69.1% | 69.8% | 65.9% | 68.2% | 67.2% | 68.2% | 68.7% | 67.0% | 66.3% | 67.7% | 68.0% | 64.6% | 66.6% | |
| 55.1% | 57.3% | 59.5% | 50.3% | 49.7% | 51.6% | 51.3% | 46.4% | 48.3% | 39.3% | 51.0% | 37.5% | 43.8% | |
| 78.2% | 77.8% | 81.3% | 66.9% | 68.6% | 71.4% | 65.2% | 67.1% | 71.4% | 101.5% | 63.4% | 65.2% | 75.3% | |
| 170.6% | 180.9% | 184.8% | 163.1% | 164.1% | 166.6% | 158.9% | 168.2% | 158.1% | 150.8% | 147.7% | 150.6% | 151.6% | |
| -101.5% | -111.1% | -118.9% | -94.9% | -96.9% | -98.4% | -90.2% | -101.3% | -91.8% | -83.1% | -79.7% | -86.0% | -85.0% | |
| – | – | 0.9% | 3.2% | – | 10.8% | 3.7% | 3.1% | 8.5% | 7.7% | 7.7% | 6.9% | 7.7% | |
| -83.0% | -141.1% | -84.8% | -95.1% | -115.5% | -82.0% | -95.0% | -118.2% | -99.6% | -90.2% | -87.9% | -95.6% | -93.2% | |
| 1.8% | 0.0% | 2.0% | 1.0% | 0.8% | 3.5% | 2.8% | 4.2% | 3.3% | -1.8% | 1.2% | 0.3% | 0.7% | |
| -84.8% | -141.1% | -86.8% | -96.1% | -116.3% | -85.5% | -97.8% | -122.3% | -102.9% | -88.4% | -89.1% | -95.9% | -93.9% | |
| -69.5% | -117.6% | -70.9% | -79.0% | -101.5% | -44.8% | -78.3% | -102.2% | -88.6% | -71.2% | -67.6% | -76.2% | -75.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.